再生医学市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001194
  • Category : Life Sciences
  • No. of Pages : 201
Buy Now

再生医学市场预计在 2023 年至 2031 年期间的复合年增长率为 15.4%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

再生医学市场报告涵盖了按类型(基于细胞的免疫疗法和细胞疗法产品、组织工程产品和基因疗法产品)和应用(肌肉骨骼疾病、伤口护理、肿瘤学、眼部疾病和糖尿病)进行的分析。该研究报告提供了全球和地区市场概况。

报告目的

Insight Partners 的《再生医学市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种商业利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

再生医学市场细分

 

类型

  • 基于细胞的免疫疗法和细胞治疗产品
  • 组织工程产品
  • 基因治疗产品
  •  

应用

  • 肌肉骨骼疾病
  • 伤口护理
  • 肿瘤学
  • 眼部疾病
  • 糖尿病
  •  

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

再生医学市场:战略洞察

Regenerative Medicine Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

再生医学市场增长动力

  • 干细胞研究推动市场增长:干细胞研究的进展推动了这一市场的发展,干细胞研究一直在彻底改变退行性疾病的治疗方法。大多数市场对基于干细胞修复或替换有缺陷的组织和问题的疗法的需求不断增加,这种趋势正在上升。组织工程和基因编辑方面的最新突破进一步打开了国际市场的大门,增加了先进药物的市场份额。市场报告表明,医疗保健的增长前景受到干细胞疗法的推动,这将推动医疗保健市场的发展。
  • 再生医学随着慢性病治疗而扩展:再生医学治疗恰好是一个相关领域,其中糖尿病、心血管疾病或神经退行性疾病等慢性病一直在增加,并且呈逐步增长趋势。再生医学具有修复受损组织的潜力,有可能极大地改变患者的治疗结果。因此,对市场的分析表明,这一趋势正在推动市场增长,因为医疗保健系统和制药公司在研究和临床试验方面投入了大量资金。因此,在这些新兴治疗解决方案的支持下,全球市场正在经历扩张。neurodegenerative conditions have been increasing and doing so progressively. Regenerative medicine has the potential to restore damaged tissues, potentially changing patient outcomes dramatically. An analysis of the market, therefore, shows that this trend is fueling market growth in that healthcare systems and pharmaceutical companies invest much in research and clinical trials. Global markets are, thus, experiencing expansion supported by these emerging therapeutic solutions.
  • 基因治疗创新推动再生医学:基因治疗创新在全球再生医学市场增长的保护伞下发挥着巨大的作用,在治疗遗传疾病方面具有变革性力量。CRISPR 和其他基因编辑技术的突破正在推动个性化医疗的发展。据说这些突破决定了市场的趋势并进一步推动业务增长。因此,随着基因疗法监管部门的批准不断增加,随着公司继续投资研发以在全球市场中占据更大份额,市场规模将进一步扩大。transformative power in the treatment of genetic disorders. Breakthroughs in CRISPR and other gene-editing technologies are advancing personal medicine. These breakthroughs are said to dictate the trend of markets and further propel business growth. Therefore, the market size will grow further as companies keep investing in research and development to obtain the upper hand in having a more significant portion of the global market as the regulatory approvals for gene therapies continue to rise.

再生医学市场未来趋势

  • 组织工程塑造器官移植的未来:新兴的组织工程趋势正在塑造再生医学的未来,尤其是在器官移植领域。由于全球缺乏捐赠器官,主要参与者正在投资开发生物工程器官的能力。SWOT 分析表明,颠覆性创新可能面临可扩展性和道德争论方面的挑战。因此,PEST 分析涉及政府资助和积极的公众认知,而市场战略涉及长期研发,以进一步改进生物工程技术和商业可行性。
  • 先进的生物制造技术增强了治疗生产:先进的生物制造技术正在彻底改变基于细胞的疗法和组织工程构造再生医学产品的生产。该市场的领导者通过新的市场策略进行创新,使其生产更加高效和可扩展。 SWOT 分析表明,这种削减成本和精简流程的优势也变成了弱点,因为产品质量下降,无法满足既定的监管标准。 PEST 分析表明,政府正在制定必要的举措,以维持生物制造行业的增长,从而使市场充满活力,技术进步推动再生解决方案的发展。
  • 监管支持加速新疗法审批:新兴再生医学市场需要更多的监管支持,以进一步推进新疗法的审批流程。各国政府正在推出再生疗法加速审查计划,并挑战主导者采取积极的市场战略,以加速产品上市。在 SWOT 分析中,更好的监管框架再次增加了进入市场的机会,尽管严格的合规条款加剧了劣势。PEST 分析表明,有利的监管有利于创新,以更有活力的方式推动该领域的研究和临床应用。

再生医学市场机会

  • 免疫疗法与再生医学融合:免疫疗法与再生医学正在融合,开辟了新的增长途径。2023 年进行的北美临床试验中,超过 30% 的试验结合使用了这些方法来增强治疗效果,尤其是在肿瘤学领域。这为大量寻求在竞争格局中实现差异化的公司提供了机会。亚太地区和欧洲地区也在研究这种融合,这推动了进一步的研究和投资。这些领域的融合将重新定义全球所有未来的治疗方式。
  • 再生医学在骨科领域获得关注:再生医学在骨科领域的应用越来越广泛,它提供了巨大的增长机会。2023 年,北美 50% 的骨科疾病治疗诊所采用了再生疗法,包括干细胞疗法。竞争分析表明,欧洲和拉丁美洲对这一领域的兴趣日益浓厚,由于人口老龄化,这两个地区对再生疗法的需求日益增加。那些开发特定骨科再生解决方案的公司将有望占据这个新兴市场的最大份额,因为该行业正在逐步转向微创和再生选择。
  • 合作研究推动再生医学进步:再生医学的创新由研究机构、医院和生物技术公司之间的合作推动。在北美,目前 62% 的临床试验共享多机构合作,体现了资源和专业知识的竞争优势。因此,随着合作企业推动发现和治疗验证的速度,存在增长机会。欧洲和亚太等地区也出现了新兴的合作框架,这导致了再生治疗的突破。

 

再生医学市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响再生医学市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的再生医学市场细分和地理位置。

Regenerative Medicine Market
  • 获取再生医学市场的区域特定数据

再生医学市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)15.4%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 基于细胞的免疫疗法和细胞治疗产品
  • 组织工程产品
  • 基因治疗产品
  •  
按应用
  • 肌肉骨骼疾病
  • 伤口护理
  • 肿瘤学
  • 眼部疾病
  • 糖尿病
  •  
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Integra 生命科学公司
  • 吉利德科学
  • 诺华
  • Vericel 公司
  • 莱特医疗
  • 美迪克斯
  • 奥西里斯治疗公司
  • 史赛克公司
  • Spark Therapies公司

 

再生医学市场参与者密度:了解其对业务动态的影响

再生医学市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在再生医学市场运营的主要公司有:

  1. Integra 生命科学公司
  2. 吉利德科学
  3. 诺华
  4. Vericel 公司
  5. 莱特医疗

免责声明上面列出的公司没有按照任何特定顺序排列。


Regenerative Medicine Market

 

  • 了解再生医学市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了再生医学市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,再生医学市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the deliverable formats of Regenerative Medicine Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Which are the key players in the Regenerative Medicine Market?

Key companies in this market are: Integra LifeSciences Corporation, Gilead Sciences, Novartis, Vericel Corporation, Wright Medical MiMedx, Osiris Therapeutics, Stryker Corporation, Spark Therapeutics

What are the future trends in the Regenerative Medicine Market?

Key future trends in this market are - Increase in stem cell research, Adoption of 3D bioprinting, Advances in tissue engineering

What is the expected CAGR of the Regenerative Medicine Market?

The Regenerative Medicine Market is expected to register a CAGR of 15.4% from 2023-2031.

What are the driving factors impacting the Regenerative Medicine Market?

The major factors impacting the Regenerative Medicine Market are: Growing Focus on Stem Cell Research, Rising Prevalence of Chronic Diseases, and Advancements in Gene Therapy

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic
11. 3M
12. Allergan Plc
13. Aspect Biosystems
14. Bluebird Bio
15. Amgen, Inc.
16. Smith and Nephew Plc
17. Corestem, Inc.
18. Organogenesis
19. Kite Pharma
20. Spark Therapeutics


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.